Improved t-cell chimerism and successful withdrawal of immunosuppression after non-myeloablative stem cell transplantation for sickle cell disease with azathioprine/hydroxyurea preconditioning added to alemtuzumab/tbi conditioning

Blood(2023)

引用 0|浏览12
暂无评分
关键词
sickle t-cell disease,immunosuppression,alemtuzumab/tbi preconditioning,non-myeloablative
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要